10 Jun 2026
Parabilis sets a record with a $670M biotech IPO
Parabilis Medicines, a high-profile startup making medicines for “undruggable” targets, raised $670 million in an initial public offering on Wednesday, a record haul for a venture-backed biotechnology company.
